TrialAntimicrobial agents and chemotherapy2018

Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials.

Preethi Krishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.